About Gala Based in San Francisco, Gala has emerged as a leader in digital health solutions, supporting over 20,000 patients in their GLP-1 treatment journeys
And start asking a better one
In this episode, Im unpacking Eli Lillys new triple agonist medication, which targets three different pathways: GLP-1, GIP, and glucagon
What they basically did was take the GLP-1 molecule and make some molecular substitutions so that it would bind more strongly to albumin in blood and would last longer in circulation. The shift from injectable to oral formulations is another important development
The MTHFR gene provides instructions for making an enzyme called methylenetetrahydrofolate reductase, which plays a crucial role in folate metabolism
Lasers in Medical Science, 32(3), 707714